213 related articles for article (PubMed ID: 7919825)
1. Development of a Babesia bovis live attenuated vaccine.
Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of older Bos taurus bulls against bovine babesiosis.
Shkap V; Leibovitz B; Krigel Y; Hammerschlag J; Marcovics A; Fish L; Molad T; Savitsky I; Mazuz M
Vet Parasitol; 2005 May; 129(3-4):235-42. PubMed ID: 15845278
[TBL] [Abstract][Full Text] [Related]
3. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
[TBL] [Abstract][Full Text] [Related]
4. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
Combrink MP; Troskie PC; Du Plessis F; Latif AA
Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
[TBL] [Abstract][Full Text] [Related]
5. Live vaccines against bovine babesiosis.
de Waal DT; Combrink MP
Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of cattle against B. bovis infection with live attenuated parasites and non-viable immunogens.
Fish L; Leibovich B; Krigel Y; McElwain T; Shkap V
Vaccine; 2008 Dec; 26 Suppl 6():G29-33. PubMed ID: 19178890
[TBL] [Abstract][Full Text] [Related]
8. Immunisation of cattle against Babesia bovis combining a multi-epitope modified vaccinia Ankara virus and a recombinant protein induce strong Th1 cell responses but fails to trigger neutralising antibodies required for protection.
Jaramillo Ortiz JM; Paoletta MS; Gravisaco MJ; López Arias LS; Montenegro VN; de la Fournière SAM; Valenzano MN; Guillemi EC; Valentini B; Echaide I; Farber MD; Wilkowsky SE
Ticks Tick Borne Dis; 2019 Oct; 10(6):101270. PubMed ID: 31445874
[TBL] [Abstract][Full Text] [Related]
9. Virulence and heterologous strain immunity of South African and Australian Babesia bovis strains with reduced pathogenicity.
De Vos AJ; Bessenger R; Fourie CG
Onderstepoort J Vet Res; 1982 Sep; 49(3):133-6. PubMed ID: 7177589
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different direct diagnostic methods to identify Babesia bovis and Babesia bigemina in animals vaccinated with live attenuated parasites.
Costa-Júnior LM; Rabelo EM; Martins Filho OA; Ribeiro MF
Vet Parasitol; 2006 Jun; 139(1-3):231-6. PubMed ID: 16580136
[TBL] [Abstract][Full Text] [Related]
11. Search for Babesia bovis vaccine candidates.
Florin-Christensen M; Schnittger L; Dominguez M; Mesplet M; Rodríguez A; Ferreri L; Asenzo G; Wilkowsky S; Farber M; Echaide I; Suarez C
Parassitologia; 2007 May; 49 Suppl 1():9-12. PubMed ID: 17691600
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
Kuttler KL; Levy MG; James MA; Ristic M
Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
[TBL] [Abstract][Full Text] [Related]
13. Attenuated vaccines for tropical theileriosis, babesiosis and heartwater: the continuing necessity.
Shkap V; de Vos AJ; Zweygarth E; Jongejan F
Trends Parasitol; 2007 Sep; 23(9):420-6. PubMed ID: 17656155
[TBL] [Abstract][Full Text] [Related]
14. Exoantigens of an attenuated strain of Babesia bovis used as a vaccine against bovine babesiosis.
Patarroyo JH; Prates AA; Tavares CA; Mafra CL; Vargas MI
Vet Parasitol; 1995 Oct; 59(3-4):189-99. PubMed ID: 8533277
[TBL] [Abstract][Full Text] [Related]
15. Advances in the development of molecular tools for the control of bovine babesiosis in Mexico.
Mosqueda J; Figueroa JV; Alvarez A; Bautista R; Falcon A; Ramos A; Canto G; Vega CA
Parassitologia; 2007 May; 49 Suppl 1():19-22. PubMed ID: 17691602
[TBL] [Abstract][Full Text] [Related]
16. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
[TBL] [Abstract][Full Text] [Related]
17. Blocking Babesia bovis vaccine reactions of dairy cattle in milk.
Combrink MP; Carr G; Mans BJ; Marais F
Onderstepoort J Vet Res; 2012 Dec; 79(1):E1-4. PubMed ID: 23327323
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with an
Bastos RG; Capelli-Peixoto J; Laughery JM; Suarez CE; Ueti MW
Front Immunol; 2023; 14():1219913. PubMed ID: 37583702
[TBL] [Abstract][Full Text] [Related]
19. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
20. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge.
Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ
Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
